Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Randomized Controlled Trial to Determine the Efficacy of Lactoferrin for the Prevention of Nosocomial Infections.

NCT01996579 is registered in ClinicalTrials.gov with Queen's University as lead sponsor.

NCT NCT01996579
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01996579 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Randomized Controlled Trial to Determine the Efficacy of Lactoferrin for the Prevention of Nosocomial Infections.
Lead sponsor
Queen's University
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2013
Completion date
September 12, 2016
Enrollment
214 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

critically ill